In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Debiotech SA

www.debiotech.com

Latest From Debiotech SA

Nightly Home Hemodialysis Gains First FDA Clearance

NxStage’s System One has received an expanded indication to treat patients overnight at home, which the company says improves quality of life.

Medical Device

NxStage Dialysis Needle Technology Gets FDA Nod

The company says its new needle technology means patients will only need to be pricked once during a dialysis procedure instead of twice which will reduce their discomfort while preserving vascular access.

Medical Device

News Briefs: Teleflex Acquires Vidacare; Integra Buys Covidien’s DuraSeal Line

Teleflex buys Vidacare Corp. for $262.5 million. Integra LifeSciences acquires Covidien’s Confluent Surgical product line, including the DuraSeal products, for $235 million, plus up to $30 million in milestone payments. W.L. Gore ordered to pay more than $850 million to C.R. Bard to partially resolve a long-running patent dispute. More news.

Medical Device

Novel Insulin Delivery Systems Pump New Life Into Diabetes Device Market

The market for insulin delivery devices is positioned to change significantly with several manufacturers gearing their products toward type 2 diabetics, who make up 90% to 95% of the diabetes patient pool in the US. These new, “pump-like” devices could offer the type 2 diabetes population better control in managing glucose levels, a solution the medical community has been seeking for a while.

Medical Device Consumer
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Biomaterials
    • Implantable Devices
    • Surgical Equipment & Devices
  • Pharmaceuticals
    • Drug Delivery
  • Therapeutic Areas
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Switzerland
  • Parent & Subsidiaries
  • Debiotech SA
  • Senior Management
  • Frederic Neftel, CEO
    Brigitte Neftel, CFO
  • Contact Info
  • Debiotech SA
    Phone: (41) 21 623 60 00
    Le Portique, Av. de Sévelin 28
    1004 Lausanne,
    Switzerland
UsernamePublicRestriction

Register